Company Filing History:
1 out of 2 
1 out of 832,880 Years Active: 1979
Title: Friedrich-Gero Kollensperger: Innovator in Therapeutic Compounds
Introduction
Friedrich-Gero Kollensperger is a notable inventor based in Linz, Austria. He has made significant contributions to the field of therapeutic agents, particularly through his innovative work on oxazolidin-2-one derivatives. With a total of 2 patents, his inventions focus on addressing various medical conditions.
Latest Patents
Kollensperger's latest patents include the development of 4-(Alpha-hydroxy-isopropyl)-5-phenyl-oxazolidin-2-one. This invention relates to new oxazolidin-2-one derivatives that are designed to treat somnipathy, tension conditions, and epilepsy in humans. The process involves administering a compound of the specified general formula to individuals suffering from these conditions. Another significant patent involves oxazolidinones as therapeutic agents, which also targets similar medical issues through the same innovative approach.
Career Highlights
Throughout his career, Kollensperger has worked with various companies, including Nordmark-werke GmbH. His work has been instrumental in advancing therapeutic solutions that benefit patients with specific health challenges.
Collaborations
Kollensperger has collaborated with notable professionals in his field, including York Hartleben and Rolf Kretzschmar. These partnerships have contributed to the development and refinement of his innovative ideas.
Conclusion
Friedrich-Gero Kollensperger stands out as an inventor dedicated to improving therapeutic treatments through his innovative patents. His work continues to influence the medical field positively.